Analysts
Scores, price targets and rating changes published by the firms we track. Informational, not advice.
Price target forecast
The average analyst target through the past year, and where analysts see the price a year from now.
Nov 6, 20260 analyst targets · 90 days
- Share price
- $44.65
- Average 1Y price target
- $47.50+6.38%
- Agreement
- Fair
Analysts agreement range is spread 15% to 30% from the average
Share priceAverage analyst target (90-day window), shaded 10th–90th percentile12-month range from the lowest to the highest current target, dashed to the average
Rating scores
Each factor is scored 1 (weak) to 5 (strong).
- Overall3
- DCF4
- Return on equity5
- Return on assets4
- Debt / equity1
- P/E2
- P/B1
Average price target
Mean of the targets analysts published in each window.
| Window | Targets | Average |
|---|---|---|
| Last month | 1 | $42.00 |
| Last quarter | 3 | $40.67 |
| Last year | 13 | $44.69 |
| All time | 20 | $47.70 |
Recent rating changes
The latest 40 changes by research firm, newest first.
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 27, 2026 | Rosenblatt | maintain | Buy | Buy |
| Oct 16, 2026 | Cantor Fitzgerald | maintain | Overweight | Overweight |
| Aug 10, 2026 | Rosenblatt | maintain | Buy | Buy |
| Aug 7, 2026 | Piper Sandler | maintain | Overweight | Overweight |
| May 29, 2026 | Barclays | maintain | Equal Weight | Equal Weight |
| May 8, 2026 | Piper Sandler | upgrade | Neutral | Overweight |
| May 8, 2026 | Mizuho | maintain | Outperform | Outperform |
| May 4, 2026 | UBS | maintain | Neutral | Neutral |
| Mar 6, 2026 | Barclays | maintain | Equal Weight | Equal Weight |
| Mar 2, 2026 | Piper Sandler | maintain | Neutral | Neutral |
| Feb 27, 2026 | UBS | maintain | Neutral | Neutral |
| Feb 27, 2026 | Oppenheimer | maintain | Outperform | Outperform |
| Feb 27, 2026 | Mizuho | maintain | Outperform | Outperform |
| Feb 24, 2026 | Rosenblatt | maintain | Buy | Buy |
| Feb 23, 2026 | UBS | maintain | Neutral | Neutral |
| Jan 20, 2026 | Oppenheimer | maintain | Outperform | Outperform |
| Jan 13, 2026 | Piper Sandler | downgrade | Overweight | Neutral |
| Jan 12, 2026 | Barclays | maintain | Equal Weight | Equal Weight |
| Jan 5, 2026 | RBC Capital | maintain | Outperform | Outperform |
| Nov 6, 2025 | Rosenblatt | maintain | Buy | Buy |
| Nov 6, 2025 | Piper Sandler | maintain | Overweight | Overweight |
| Nov 6, 2025 | JP Morgan | maintain | Neutral | Neutral |
| Nov 6, 2025 | Baird | maintain | Outperform | Outperform |
| Oct 17, 2025 | Rosenblatt | upgrade | Neutral | Buy |
| Aug 7, 2025 | UBS | maintain | Neutral | Neutral |
| Aug 7, 2025 | Rosenblatt | downgrade | Buy | Neutral |
| Aug 7, 2025 | Piper Sandler | maintain | Overweight | Overweight |
| Aug 7, 2025 | Oppenheimer | maintain | Outperform | Outperform |
| Aug 7, 2025 | Goldman Sachs | maintain | Sell | Sell |
| Jul 30, 2025 | Baird | maintain | Outperform | Outperform |
| Jul 17, 2025 | Oppenheimer | maintain | Outperform | Outperform |
| Jul 7, 2025 | Keybanc | maintain | Overweight | Overweight |
| May 8, 2025 | UBS | maintain | Neutral | Neutral |
| May 8, 2025 | Rosenblatt | maintain | Buy | Buy |
| May 8, 2025 | RBC Capital | maintain | Outperform | Outperform |
| May 8, 2025 | Oppenheimer | maintain | Outperform | Outperform |
| May 8, 2025 | Keybanc | maintain | Overweight | Overweight |
| May 5, 2025 | Rosenblatt | maintain | Buy | Buy |
| Apr 16, 2025 | Keybanc | maintain | Overweight | Overweight |
| Apr 15, 2025 | Mizuho | maintain | Outperform | Outperform |